Troikaa Pharmaceuticals

Troikaa Pharmaceuticals, established in 1983, is a globally recognized entity within the Pharmaceutical and Healthcare sectors. The company distinguishes itself through its specialization in Novel Drug Delivery Systems (NDDS), driving innovation in how medications are administered. This focus underpins its commitment to developing advanced pharmaceutical solutions.

The company boasts a diverse portfolio, featuring over 50 brands across critical therapeutic areas including Pain Management, Gynaecology, and Critical Care. Supported by state-of-the-art manufacturing facilities accredited by international regulatory bodies, Troikaa Pharmaceuticals ensures high-quality production standards. Its operational scale is significant, with a workforce ranging from 1,000 to 5,000 employees and a revenue of $116.4M. The company actively pursues expansion, aiming to establish a presence in 120 countries worldwide.

Troikaa Pharmaceuticals cultivates a culture that values its employees, fostering creativity and professional development, making it an attractive partner for multinational pharmaceutical corporations. This dedication to its people is a cornerstone of its operational philosophy. Meet Troikaa Pharmaceuticals' team to understand the expertise driving its innovative endeavors and global outreach. The company's strategic partnerships and commitment to quality position it as a key player in the global pharmaceutical landscape.